CytoMed Therapeutics (GDTC) Q4 2023 Earnings

Feb 28Expected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.06
-0.04
-0.02
0

Details

Expected EPS
-0.06
Actual EPS
0
Surprise EPS
0.06
Surprise Percent
+100%

Description

⁨CytoMed Therapeutics⁩ (⁦GDTC⁩) has reported earnings of ⁦0⁩ per share for ⁦Q4 2023⁩.

0 Comments

Share your thoughts